Adherence and Convenience Drive Long-Term Market Share Obesity is a chronic condition requiring indefinite treatment
Opportunity: USD 15,000-22,000 million
Mullally, Jamie A
Academic Press, Cambridge, pp 279302 Ma X, Hui H, Liu Z, He G, Hu J, Meng J, Guan L, Luo X (2009) Poly-GLP-1, a novel long-lasting glucagon-like peptide-1 polymer, ameliorates hyperglycaemia by improving insulin sensitivity and increasing pancreatic beta-cell proliferation
DPN is classified as a microvascular late complication of diabetes and therefore shares risk factors with other micro- and macrovascular complications (duration of diabetes, glycemic control, age, hypertension, dyslipidemia, smoking and obesity) [11]